All-or-Nothing: Inside CMS Audits of Nursing Home Quality Measures and Their Impact on Reimbursement and Star Ratings

Why It Matters

The penalties directly affect cash flow and public quality ratings, influencing both reimbursement and market reputation for skilled nursing facilities.

Key Takeaways

• 1,500 nursing homes audited; non‑compliance triggers 2% payment cut
• Audits demand all 10 resident MDS records submitted within 45 days
• Focus areas: Section GG functional scores and skin integrity documentation
• Hybrid antipsychotic measure can cause star rating downgrade and data suppression
• Early iQIES notification and strict calendar‑day deadlines demand constant monitoring

Pulse Analysis

The Centers for Medicare & Medicaid Services (CMS) rolled out a new data‑validation process for the Quality Reporting Program (QRP) in early 2026, targeting roughly 10 % of the nation’s 15,300 certified nursing homes. By scrutinizing Minimum Data Set (MDS) elements that feed into value‑based purchasing calculations, CMS aims to ensure that reimbursement and quality‑star ratings reflect actual care performance. Facilities that receive a selection notice via the Internet Quality Improvement Evaluation System (iQIES) must acknowledge the audit within five business days and deliver the required documentation within 45 calendar days, or risk a 2 % reduction in their annual payment update.

The audit protocol is decidedly all‑or‑nothing. CMS may request up to ten resident records—typically a mix of admissions and discharges—and any shortfall, even if most documents are provided, is treated as non‑compliance. Reviewers concentrate on Section GG functional status scores, skin‑integrity assessments, and related nursing notes spanning the three‑ to seven‑day windows around admission and discharge. Because the deadline counts calendar days from the moment the notice is posted on iQIES, facilities must monitor the portal continuously and have pre‑built workflows that can assemble and format files to CMS’s exact specifications.

The redesign of the antipsychotic quality measure into a ‘hybrid’ metric adds another layer of risk. In addition to MDS data, auditors will cross‑check pharmacy dispensing records, physician claims, hospice claims, and insurance enrollment to verify exclusions and inclusions. Failure to satisfy a schizophrenia‑related audit can trigger not only the standard 2 % payment cut but also a one‑star downgrade of the long‑stay quality rating for six months and a 12‑month suppression of the antipsychotic measure. Proactive strategies—such as maintaining real‑time antipsychotic inventories, aligning billing and clinical teams, and conducting internal mock audits—are becoming essential for facilities that wish to protect both revenue streams and public reputation.